Skip to main content

Biogen to slash 1,000 jobs as it looks to save $700 million

Biotech giant's cost-cutting effort comes amid the launch of its Alzheimer's treatment, Leqembi.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.